203 related articles for article (PubMed ID: 16481149)
1. Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication.
De Hert MA; van Winkel R; Van Eyck D; Hanssens L; Wampers M; Scheen A; Peuskens J
Schizophr Res; 2006 Mar; 83(1):87-93. PubMed ID: 16481149
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder.
van Winkel R; De Hert M; Van Eyck D; Hanssens L; Wampers M; Scheen A; Peuskens J
Bipolar Disord; 2008 Mar; 10(2):342-8. PubMed ID: 18271914
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of metabolic syndrome among an Iranian cohort of inpatients with schizophrenia.
Rezaei O; Khodaie-Ardakani MR; Mandegar MH; Dogmehchi E; Goodarzynejad H
Int J Psychiatry Med; 2009; 39(4):451-62. PubMed ID: 20391865
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome and antipsychotic monotherapy treatment among schizophrenia patients in Malaysia.
Said MA; Hatim A; Habil MH; Zafidah W; Haslina MY; Badiah Y; Ramli MA; Ananjit S; Sapini Y; Shah M; Mahmud B; Bulgiba A; Hairi NN
Prev Med; 2013; 57 Suppl():S50-3. PubMed ID: 23337566
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome and cardiovascular risk among patients with schizophrenia receiving antipsychotics in Malaysia.
Said MA; Sulaiman AH; Habil MH; Das S; Bakar AK; Yusoff RM; Loo TH; Bakar SA
Singapore Med J; 2012 Dec; 53(12):801-7. PubMed ID: 23268153
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.
McEvoy JP; Meyer JM; Goff DC; Nasrallah HA; Davis SM; Sullivan L; Meltzer HY; Hsiao J; Scott Stroup T; Lieberman JA
Schizophr Res; 2005 Dec; 80(1):19-32. PubMed ID: 16137860
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome among psychiatric inpatients with schizophrenia in Indonesia.
Marthoenis M; Aichberger MC; Puteh I; Syahrial S; Schouler-Ocak M
Asian J Psychiatr; 2015 Jun; 15():10-4. PubMed ID: 25910596
[TBL] [Abstract][Full Text] [Related]
8. [Prevalence of metabolic syndrome in Spanish patients with schizophrenia and overweight. The CRESSOB Study].
Gutiérrez-Rojas L; Azanza JR; Bernardo M; Rojo L; Mesa F; Martínez-Ortega JM
Actas Esp Psiquiatr; 2014; 42(1):9-17. PubMed ID: 24504989
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
Athyros VG; Ganotakis ES; Elisaf MS; Liberopoulos EN; Goudevenos IA; Karagiannis A;
Int J Cardiol; 2007 Apr; 117(2):204-10. PubMed ID: 16854482
[TBL] [Abstract][Full Text] [Related]
10. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of the metabolic syndrome in schizophrenic patients receiving second-generation antipsychotic agents--a cross-sectional study.
Kagal UA; Torgal SS; Patil NM; Malleshappa A
J Pharm Pract; 2012 Jun; 25(3):368-73. PubMed ID: 22551560
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study.
Bener A; Zirie M; Musallam M; Khader YS; Al-Hamaq AO
Metab Syndr Relat Disord; 2009 Jun; 7(3):221-9. PubMed ID: 19320557
[TBL] [Abstract][Full Text] [Related]
13. A two fold risk of metabolic syndrome in a sample of patients with schizophrenia: do consanguinity and family history increase risk?
Bener A; Al-Hamaq AO; Dafeeah EE
Diabetes Metab Syndr; 2014; 8(1):24-9. PubMed ID: 24661754
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome in first episode schizophrenia - a randomized double-blind controlled, short-term prospective study.
Saddichha S; Manjunatha N; Ameen S; Akhtar S
Schizophr Res; 2008 Apr; 101(1-3):266-72. PubMed ID: 18262771
[TBL] [Abstract][Full Text] [Related]
15. Atypical antipsychotic drugs, schizophrenia, and metabolic syndrome in non-Euro-American societies.
Bou Khalil R
Clin Neuropharmacol; 2012; 35(3):141-7. PubMed ID: 22592510
[TBL] [Abstract][Full Text] [Related]
16. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
[TBL] [Abstract][Full Text] [Related]
17. The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome.
Meyer JM; Nasrallah HA; McEvoy JP; Goff DC; Davis SM; Chakos M; Patel JK; Keefe RS; Stroup TS; Lieberman JA
Schizophr Res; 2005 Dec; 80(1):9-18. PubMed ID: 16125372
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and predictors of metabolic syndrome among patients attending an outpatient clozapine clinic in Australia.
Brunero S; Lamont S; Fairbrother G
Arch Psychiatr Nurs; 2009 Jun; 23(3):261-8. PubMed ID: 19446781
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of the metabolic syndrome in Danish psychiatric outpatients treated with antipsychotics.
Krane-Gartiser K; Breum L; Glümrr C; Linneberg A; Madsen M; Køster A; Jepsen PW; Fink-Jensen A
Nord J Psychiatry; 2011 Oct; 65(5):345-52. PubMed ID: 21428861
[TBL] [Abstract][Full Text] [Related]
20. Metabolic complications of schizophrenia and antipsychotic medications--an updated review.
Yogaratnam J; Biswas N; Vadivel R; Jacob R
East Asian Arch Psychiatry; 2013 Mar; 23(1):21-8. PubMed ID: 23535629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
